BIOMAT Database Logo BIOMAT Database Logo

Topical application of 3-carbethoxypsoralen plus UVA in the treatment of psoriasis. 1985

S Kimura, and N Mizuno, and S Hirano, and K Yoshikawa

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010328 Patch Tests Skin tests in which the sensitizer is applied to a patch of cotton cloth or gauze held in place for approximately 48-72 hours. It is used for the elicitation of a contact hypersensitivity reaction. Patch Testing,Patch Test,Patch Testings,Test, Patch,Testing, Patch,Testings, Patch,Tests, Patch
D010787 Photosensitivity Disorders Abnormal responses to sunlight or artificial light due to extreme reactivity of light-absorbing molecules in tissues. It refers almost exclusively to skin photosensitivity, including sunburn, reactions due to repeated prolonged exposure in the absence of photosensitizing factors, and reactions requiring photosensitizing factors such as photosensitizing agents and certain diseases. With restricted reference to skin tissue, it does not include photosensitivity of the eye to light, as in photophobia or photosensitive epilepsy. Actinic Reticuloid Syndrome,Dermatitis, Actinic,Photodermatitis,Chronic Actinic Dermatitis,Photosensitization,Actinic Dermatitides,Actinic Dermatitides, Chronic,Actinic Dermatitis,Actinic Dermatitis, Chronic,Actinic Reticuloid Syndromes,Chronic Actinic Dermatitides,Dermatitides, Actinic,Dermatitides, Chronic Actinic,Dermatitis, Chronic Actinic,Disorder, Photosensitivity,Disorders, Photosensitivity,Photodermatitides,Photosensitivity Disorder,Reticuloid Syndrome, Actinic,Reticuloid Syndromes, Actinic,Syndrome, Actinic Reticuloid,Syndromes, Actinic Reticuloid
D011564 Furocoumarins Polycyclic compounds consisting of a furan ring fused with coumarin. They commonly occur in PLANTS, especially UMBELLIFERAE and RUTACEAE, as well as PSORALEA. Furanocoumarin,Furanocoumarins,Furocoumarin,Psoralens,Angelicins
D011565 Psoriasis A common genetically determined, chronic, inflammatory skin disease characterized by rounded erythematous, dry, scaling patches. The lesions have a predilection for nails, scalp, genitalia, extensor surfaces, and the lumbosacral region. Accelerated epidermopoiesis is considered to be the fundamental pathologic feature in psoriasis. Palmoplantaris Pustulosis,Pustular Psoriasis of Palms and Soles,Pustulosis Palmaris et Plantaris,Pustulosis of Palms and Soles,Psoriases
D011701 PUVA Therapy Photochemotherapy using PSORALENS as the photosensitizing agent and ultraviolet light type A (UVA). Psoralen Ultraviolet A Therapy,Therapy, PUVA,PUVA Therapies,Therapies, PUVA
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

S Kimura, and N Mizuno, and S Hirano, and K Yoshikawa
Enzymatic recognition and biological effects of DNA damage induced by 3-carbethoxypsoralen plus UVA.
June 1993, Mutation research,
S Kimura, and N Mizuno, and S Hirano, and K Yoshikawa
Topical hematoporphyrin plus UVA for treatment of alopecia areata.
December 1987, Photo-dermatology,
S Kimura, and N Mizuno, and S Hirano, and K Yoshikawa
Comparative study of Puvasol and Puvasol plus topical application in treatment of psoriasis.
July 1983, Indian journal of dermatology,
S Kimura, and N Mizuno, and S Hirano, and K Yoshikawa
Trioxsalen bath plus UVA effective and safe in the treatment of psoriasis.
December 1978, The British journal of dermatology,
S Kimura, and N Mizuno, and S Hirano, and K Yoshikawa
3-Carbethoxypsoralen.
January 1986, IARC monographs on the evaluation of the carcinogenic risk of chemicals to humans,
S Kimura, and N Mizuno, and S Hirano, and K Yoshikawa
Evidence for preferential repair of 3-carbethoxypsoralen plus UVA induced DNA lesions in the active MAT alpha locus in Saccharomyces cerevisiae using the UvrABC assay.
September 1993, Mutagenesis,
S Kimura, and N Mizuno, and S Hirano, and K Yoshikawa
Inefficacy of topical methoxalen plus UVA for palmoplantar pustulosis.
January 1981, Acta dermato-venereologica,
S Kimura, and N Mizuno, and S Hirano, and K Yoshikawa
Photochemotherapy (PUVA) of psoriasis using 3-carbethoxypsoralen, a non-carcinogenic compound in mice.
October 1979, The British journal of dermatology,
S Kimura, and N Mizuno, and S Hirano, and K Yoshikawa
Trioxsalen bath plus UVA treatment of psoriasis. Plasma concentration of the drug and clinical results.
January 1981, Acta dermato-venereologica,
S Kimura, and N Mizuno, and S Hirano, and K Yoshikawa
Effect of 8-methoxypsoralen plus UVA on psoriasis leukotactic factor.
February 1979, The Journal of investigative dermatology,
Copied contents to your clipboard!